Rhinosinusitis — Early Versus Late Surgical Wait Times
Citation(s)
Ben-Shlomo Y, Kuh D A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002 Apr;31(2):285-93.
Bhattacharyya, N , Orlandi, R., & Martinson, M. (2010). Cost Burden of Chronic Rhinosinusitis A Claims-Based Study. Otolaryngology--Head and Neck Surgery, 143(2 suppl), P127-P127.
Chen Y, Dales R, Lin M The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope. 2003 Jul;113(7):1199-205.
Cherry DK, Woodwell DA National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002 Jun 5;(328):1-32.
Damm M, Quante G, Jungehuelsing M, Stennert E Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope. 2002 Feb;112(2):310-5.
Diggle, P J., Heagerty, P., Liang K-Y. and Zeger, S.L. (2002). Analysis of Longitudinal Data (second edition). Oxford: Oxford University Press.
EuroQoL Group EQ-5D. [Online] [Cited: January 30, 2013.] http://www.euroqol.org/.
Gliklich RE, Metson R The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995 Jul;113(1):104-9.
Mickleburgh, R (2013, January 18). Ministers says BC wait lists too long. The Globe and Mail, Health Care, http://m.theglobeandmail.com/news/british-columbia/minister-says-bc-wait-lists-too-long/article7508904/?service=mobile (accessed on January 30, 2013).
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
